Menu
Back to Journals » OncoTargets and Therapy » Volume 10
Original Research
VTD-melphalan is well tolerated and results in very high rates of stringent CR and MRD-negative status in multiple myeloma
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 8,561 | Dovepress* | 7,454+ | 1,425 | 8,879 | |
| PubMed Central* | 1,107 | 284 | 1,391 | ||
| Totals | 8,561 | 1,709 | 10,270 | ||
| *Since 6 January 2017 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 4 | 0 | 0 | 0 | 2 | 2 |
View citations on PubMed Central and Google Scholar